The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Peanut Allergy Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Peanut Allergy Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Peanut Allergy Therapeutics market size is estimated to be worth US$ 698 million in 2021 and is forecast to a readjusted size of USD 5942.9 million by 2028 with a CAGR of 35.8% during review period. Hospital Pharmacy accounting for % of the Peanut Allergy Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Epinephrine Injection segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Peanut Allergy Therapeutics include Mylan, Bayer, UCB Pharma, J & J, and Perrigo, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Peanut Allergy Therapeutics market is split by Type and by Distribution Channel. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Distribution Channel. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Market segment by Distribution Channel, can be divided into
Hospital Pharmacy
Retail Pharmacy
Other
Market segment by players, this report covers
Mylan
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Peanut Allergy Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Peanut Allergy Therapeutics, with revenue, gross margin and global market share of Peanut Allergy Therapeutics from 2019 to 2022.
Chapter 3, the Peanut Allergy Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Peanut Allergy Therapeutics market forecast, by regions, type and distribution channel, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Peanut Allergy Therapeutics research findings and conclusion, appendix and data source.
Geographical Area
Global
The Peanut Allergy Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Peanut Allergy Therapeutics market size is estimated to be worth US$ 698 million in 2021 and is forecast to a readjusted size of USD 5942.9 million by 2028 with a CAGR of 35.8% during review period. Hospital Pharmacy accounting for % of the Peanut Allergy Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Epinephrine Injection segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Peanut Allergy Therapeutics include Mylan, Bayer, UCB Pharma, J & J, and Perrigo, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Peanut Allergy Therapeutics market is split by Type and by Distribution Channel. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Distribution Channel. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Market segment by Distribution Channel, can be divided into
Hospital Pharmacy
Retail Pharmacy
Other
Market segment by players, this report covers
Mylan
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Peanut Allergy Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Peanut Allergy Therapeutics, with revenue, gross margin and global market share of Peanut Allergy Therapeutics from 2019 to 2022.
Chapter 3, the Peanut Allergy Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Peanut Allergy Therapeutics market forecast, by regions, type and distribution channel, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Peanut Allergy Therapeutics research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Peanut Allergy Therapeutics
1.2 Classification of Peanut Allergy Therapeutics by Type
1.2.1 Overview: Global Peanut Allergy Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Peanut Allergy Therapeutics Revenue Market Share by Type in 2021
1.2.3 Epinephrine Injection
1.2.4 Antihistamines
1.2.5 Oral Immunotherapy
1.2.6 Other
1.3 Global Peanut Allergy Therapeutics Market by Distribution Channel
1.3.1 Overview: Global Peanut Allergy Therapeutics Market Size by Distribution Channel: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Peanut Allergy Therapeutics Market Size & Forecast
1.5 Global Peanut Allergy Therapeutics Market Size and Forecast by Region
1.5.1 Global Peanut Allergy Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Peanut Allergy Therapeutics Market Size by Region, (2017-2022)
1.5.3 North America Peanut Allergy Therapeutics Market Size and Prospect (2017-2028)
1.5.4 Europe Peanut Allergy Therapeutics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Peanut Allergy Therapeutics Market Size and Prospect (2017-2028)
1.5.6 South America Peanut Allergy Therapeutics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Peanut Allergy Therapeutics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Peanut Allergy Therapeutics Market Drivers
1.6.2 Peanut Allergy Therapeutics Market Restraints
1.6.3 Peanut Allergy Therapeutics Trends Analysis
2 Company Profiles
2.1 Mylan
2.1.1 Mylan Details
2.1.2 Mylan Major Business
2.1.3 Mylan Peanut Allergy Therapeutics Product and Solutions
2.1.4 Mylan Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Mylan Recent Developments and Future Plans
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Peanut Allergy Therapeutics Product and Solutions
2.2.4 Bayer Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Bayer Recent Developments and Future Plans
2.3 UCB Pharma
2.3.1 UCB Pharma Details
2.3.2 UCB Pharma Major Business
2.3.3 UCB Pharma Peanut Allergy Therapeutics Product and Solutions
2.3.4 UCB Pharma Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 UCB Pharma Recent Developments and Future Plans
2.4 J & J
2.4.1 J & J Details
2.4.2 J & J Major Business
2.4.3 J & J Peanut Allergy Therapeutics Product and Solutions
2.4.4 J & J Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 J & J Recent Developments and Future Plans
2.5 Perrigo
2.5.1 Perrigo Details
2.5.2 Perrigo Major Business
2.5.3 Perrigo Peanut Allergy Therapeutics Product and Solutions
2.5.4 Perrigo Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Perrigo Recent Developments and Future Plans
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business
2.6.3 GSK Peanut Allergy Therapeutics Product and Solutions
2.6.4 GSK Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 GSK Recent Developments and Future Plans
2.7 Kaleo
2.7.1 Kaleo Details
2.7.2 Kaleo Major Business
2.7.3 Kaleo Peanut Allergy Therapeutics Product and Solutions
2.7.4 Kaleo Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Kaleo Recent Developments and Future Plans
2.8 Amneal Pharma
2.8.1 Amneal Pharma Details
2.8.2 Amneal Pharma Major Business
2.8.3 Amneal Pharma Peanut Allergy Therapeutics Product and Solutions
2.8.4 Amneal Pharma Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Amneal Pharma Recent Developments and Future Plans
2.9 ALK Abello
2.9.1 ALK Abello Details
2.9.2 ALK Abello Major Business
2.9.3 ALK Abello Peanut Allergy Therapeutics Product and Solutions
2.9.4 ALK Abello Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 ALK Abello Recent Developments and Future Plans
2.10 Aimmune Therapeutics
2.10.1 Aimmune Therapeutics Details
2.10.2 Aimmune Therapeutics Major Business
2.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Product and Solutions
2.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Aimmune Therapeutics Recent Developments and Future Plans
2.11 HUAPONT Pharm
2.11.1 HUAPONT Pharm Details
2.11.2 HUAPONT Pharm Major Business
2.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Product and Solutions
2.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 HUAPONT Pharm Recent Developments and Future Plans
2.12 Allergy Therapeutics
2.12.1 Allergy Therapeutics Details
2.12.2 Allergy Therapeutics Major Business
2.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Product and Solutions
2.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Allergy Therapeutics Recent Developments and Future Plans
2.13 ASIT Biotech
2.13.1 ASIT Biotech Details
2.13.2 ASIT Biotech Major Business
2.13.3 ASIT Biotech Peanut Allergy Therapeutics Product and Solutions
2.13.4 ASIT Biotech Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 ASIT Biotech Recent Developments and Future Plans
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Peanut Allergy Therapeutics Product and Solutions
2.14.4 Sanofi Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Sanofi Recent Developments and Future Plans
2.15 DBV Technologies
2.15.1 DBV Technologies Details
2.15.2 DBV Technologies Major Business
2.15.3 DBV Technologies Peanut Allergy Therapeutics Product and Solutions
2.15.4 DBV Technologies Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 DBV Technologies Recent Developments and Future Plans
2.16 HAL Allergy
2.16.1 HAL Allergy Details
2.16.2 HAL Allergy Major Business
2.16.3 HAL Allergy Peanut Allergy Therapeutics Product and Solutions
2.16.4 HAL Allergy Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 HAL Allergy Recent Developments and Future Plans
2.17 Intrommune Therapeutics
2.17.1 Intrommune Therapeutics Details
2.17.2 Intrommune Therapeutics Major Business
2.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Product and Solutions
2.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Intrommune Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Peanut Allergy Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Peanut Allergy Therapeutics Players Market Share in 2021
3.2.2 Top 10 Peanut Allergy Therapeutics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Peanut Allergy Therapeutics Players Head Office, Products and Services Provided
3.4 Peanut Allergy Therapeutics Mergers & Acquisitions
3.5 Peanut Allergy Therapeutics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Peanut Allergy Therapeutics Revenue and Market Share by Type (2017-2022)
4.2 Global Peanut Allergy Therapeutics Market Forecast by Type (2023-2028)
5 Market Size Segment by Distribution Channel
5.1 Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2017-2022)
5.2 Global Peanut Allergy Therapeutics Market Forecast by Distribution Channel (2023-2028)
6 North America by Country, by Type, and by Distribution Channel
6.1 North America Peanut Allergy Therapeutics Revenue by Type (2017-2028)
6.2 North America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2028)
6.3 North America Peanut Allergy Therapeutics Market Size by Country
6.3.1 North America Peanut Allergy Therapeutics Revenue by Country (2017-2028)
6.3.2 United States Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
6.3.3 Canada Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
6.3.4 Mexico Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Distribution Channel
7.1 Europe Peanut Allergy Therapeutics Revenue by Type (2017-2028)
7.2 Europe Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2028)
7.3 Europe Peanut Allergy Therapeutics Market Size by Country
7.3.1 Europe Peanut Allergy Therapeutics Revenue by Country (2017-2028)
7.3.2 Germany Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
7.3.3 France Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
7.3.5 Russia Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
7.3.6 Italy Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Distribution Channel
8.1 Asia-Pacific Peanut Allergy Therapeutics Revenue by Type (2017-2028)
8.2 Asia-Pacific Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2028)
8.3 Asia-Pacific Peanut Allergy Therapeutics Market Size by Region
8.3.1 Asia-Pacific Peanut Allergy Therapeutics Revenue by Region (2017-2028)
8.3.2 China Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
8.3.3 Japan Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
8.3.4 South Korea Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
8.3.5 India Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
8.3.7 Australia Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Distribution Channel
9.1 South America Peanut Allergy Therapeutics Revenue by Type (2017-2028)
9.2 South America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2028)
9.3 South America Peanut Allergy Therapeutics Market Size by Country
9.3.1 South America Peanut Allergy Therapeutics Revenue by Country (2017-2028)
9.3.2 Brazil Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
9.3.3 Argentina Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Distribution Channel
10.1 Middle East & Africa Peanut Allergy Therapeutics Revenue by Type (2017-2028)
10.2 Middle East & Africa Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2028)
10.3 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country
10.3.1 Middle East & Africa Peanut Allergy Therapeutics Revenue by Country (2017-2028)
10.3.2 Turkey Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
10.3.4 UAE Peanut Allergy Therapeutics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Peanut Allergy Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Peanut Allergy Therapeutics Revenue by Distribution Channel, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Peanut Allergy Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Peanut Allergy Therapeutics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Peanut Allergy Therapeutics Revenue Market Share by Region (2023-2028)
Table 6. Mylan Corporate Information, Head Office, and Major Competitors
Table 7. Mylan Major Business
Table 8. Mylan Peanut Allergy Therapeutics Product and Solutions
Table 9. Mylan Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Bayer Corporate Information, Head Office, and Major Competitors
Table 11. Bayer Major Business
Table 12. Bayer Peanut Allergy Therapeutics Product and Solutions
Table 13. Bayer Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. UCB Pharma Corporate Information, Head Office, and Major Competitors
Table 15. UCB Pharma Major Business
Table 16. UCB Pharma Peanut Allergy Therapeutics Product and Solutions
Table 17. UCB Pharma Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. J & J Corporate Information, Head Office, and Major Competitors
Table 19. J & J Major Business
Table 20. J & J Peanut Allergy Therapeutics Product and Solutions
Table 21. J & J Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Perrigo Corporate Information, Head Office, and Major Competitors
Table 23. Perrigo Major Business
Table 24. Perrigo Peanut Allergy Therapeutics Product and Solutions
Table 25. Perrigo Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. GSK Corporate Information, Head Office, and Major Competitors
Table 27. GSK Major Business
Table 28. GSK Peanut Allergy Therapeutics Product and Solutions
Table 29. GSK Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Kaleo Corporate Information, Head Office, and Major Competitors
Table 31. Kaleo Major Business
Table 32. Kaleo Peanut Allergy Therapeutics Product and Solutions
Table 33. Kaleo Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Amneal Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Amneal Pharma Major Business
Table 36. Amneal Pharma Peanut Allergy Therapeutics Product and Solutions
Table 37. Amneal Pharma Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. ALK Abello Corporate Information, Head Office, and Major Competitors
Table 39. ALK Abello Major Business
Table 40. ALK Abello Peanut Allergy Therapeutics Product and Solutions
Table 41. ALK Abello Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Aimmune Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Aimmune Therapeutics Major Business
Table 44. Aimmune Therapeutics Peanut Allergy Therapeutics Product and Solutions
Table 45. Aimmune Therapeutics Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. HUAPONT Pharm Corporate Information, Head Office, and Major Competitors
Table 47. HUAPONT Pharm Major Business
Table 48. HUAPONT Pharm Peanut Allergy Therapeutics Product and Solutions
Table 49. HUAPONT Pharm Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Allergy Therapeutics Corporate Information, Head Office, and Major Competitors
Table 51. Allergy Therapeutics Major Business
Table 52. Allergy Therapeutics Peanut Allergy Therapeutics Product and Solutions
Table 53. Allergy Therapeutics Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. ASIT Biotech Corporate Information, Head Office, and Major Competitors
Table 55. ASIT Biotech Major Business
Table 56. ASIT Biotech Peanut Allergy Therapeutics Product and Solutions
Table 57. ASIT Biotech Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Sanofi Corporate Information, Head Office, and Major Competitors
Table 59. Sanofi Major Business
Table 60. Sanofi Peanut Allergy Therapeutics Product and Solutions
Table 61. Sanofi Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. DBV Technologies Corporate Information, Head Office, and Major Competitors
Table 63. DBV Technologies Major Business
Table 64. DBV Technologies Peanut Allergy Therapeutics Product and Solutions
Table 65. DBV Technologies Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. HAL Allergy Corporate Information, Head Office, and Major Competitors
Table 67. HAL Allergy Major Business
Table 68. HAL Allergy Peanut Allergy Therapeutics Product and Solutions
Table 69. HAL Allergy Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Intrommune Therapeutics Corporate Information, Head Office, and Major Competitors
Table 71. Intrommune Therapeutics Major Business
Table 72. Intrommune Therapeutics Peanut Allergy Therapeutics Product and Solutions
Table 73. Intrommune Therapeutics Peanut Allergy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Global Peanut Allergy Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 75. Global Peanut Allergy Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 76. Breakdown of Peanut Allergy Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Peanut Allergy Therapeutics Players Head Office, Products and Services Provided
Table 78. Peanut Allergy Therapeutics Mergers & Acquisitions in the Past Five Years
Table 79. Peanut Allergy Therapeutics New Entrants and Expansion Plans
Table 80. Global Peanut Allergy Therapeutics Revenue (USD Million) by Type (2017-2022)
Table 81. Global Peanut Allergy Therapeutics Revenue Share by Type (2017-2022)
Table 82. Global Peanut Allergy Therapeutics Revenue Forecast by Type (2023-2028)
Table 83. Global Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022)
Table 84. Global Peanut Allergy Therapeutics Revenue Forecast by Distribution Channel (2023-2028)
Table 85. North America Peanut Allergy Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 86. North America Peanut Allergy Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 87. North America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022) & (USD Million)
Table 88. North America Peanut Allergy Therapeutics Revenue by Distribution Channel (2023-2028) & (USD Million)
Table 89. North America Peanut Allergy Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 90. North America Peanut Allergy Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 91. Europe Peanut Allergy Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 92. Europe Peanut Allergy Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 93. Europe Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022) & (USD Million)
Table 94. Europe Peanut Allergy Therapeutics Revenue by Distribution Channel (2023-2028) & (USD Million)
Table 95. Europe Peanut Allergy Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 96. Europe Peanut Allergy Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 97. Asia-Pacific Peanut Allergy Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 98. Asia-Pacific Peanut Allergy Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 99. Asia-Pacific Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022) & (USD Million)
Table 100. Asia-Pacific Peanut Allergy Therapeutics Revenue by Distribution Channel (2023-2028) & (USD Million)
Table 101. Asia-Pacific Peanut Allergy Therapeutics Revenue by Region (2017-2022) & (USD Million)
Table 102. Asia-Pacific Peanut Allergy Therapeutics Revenue by Region (2023-2028) & (USD Million)
Table 103. South America Peanut Allergy Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 104. South America Peanut Allergy Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 105. South America Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022) & (USD Million)
Table 106. South America Peanut Allergy Therapeutics Revenue by Distribution Channel (2023-2028) & (USD Million)
Table 107. South America Peanut Allergy Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 108. South America Peanut Allergy Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 109. Middle East & Africa Peanut Allergy Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 110. Middle East & Africa Peanut Allergy Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 111. Middle East & Africa Peanut Allergy Therapeutics Revenue by Distribution Channel (2017-2022) & (USD Million)
Table 112. Middle East & Africa Peanut Allergy Therapeutics Revenue by Distribution Channel (2023-2028) & (USD Million)
Table 113. Middle East & Africa Peanut Allergy Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 114. Middle East & Africa Peanut Allergy Therapeutics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Peanut Allergy Therapeutics Picture
Figure 2. Global Peanut Allergy Therapeutics Revenue Market Share by Type in 2021
Figure 3. Epinephrine Injection
Figure 4. Antihistamines
Figure 5. Oral Immunotherapy
Figure 6. Other
Figure 7. Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel in 2021
Figure 8. Hospital Pharmacy Picture
Figure 9. Retail Pharmacy Picture
Figure 10. Other Picture
Figure 11. Global Peanut Allergy Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Peanut Allergy Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Peanut Allergy Therapeutics Revenue Market Share by Region (2017-2028)
Figure 14. Global Peanut Allergy Therapeutics Revenue Market Share by Region in 2021
Figure 15. North America Peanut Allergy Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Peanut Allergy Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Peanut Allergy Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Peanut Allergy Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Peanut Allergy Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Peanut Allergy Therapeutics Market Drivers
Figure 21. Peanut Allergy Therapeutics Market Restraints
Figure 22. Peanut Allergy Therapeutics Market Trends
Figure 23. Mylan Recent Developments and Future Plans
Figure 24. Bayer Recent Developments and Future Plans
Figure 25. UCB Pharma Recent Developments and Future Plans
Figure 26. J & J Recent Developments and Future Plans
Figure 27. Perrigo Recent Developments and Future Plans
Figure 28. GSK Recent Developments and Future Plans
Figure 29. Kaleo Recent Developments and Future Plans
Figure 30. Amneal Pharma Recent Developments and Future Plans
Figure 31. ALK Abello Recent Developments and Future Plans
Figure 32. Aimmune Therapeutics Recent Developments and Future Plans
Figure 33. HUAPONT Pharm Recent Developments and Future Plans
Figure 34. Allergy Therapeutics Recent Developments and Future Plans
Figure 35. ASIT Biotech Recent Developments and Future Plans
Figure 36. Sanofi Recent Developments and Future Plans
Figure 37. DBV Technologies Recent Developments and Future Plans
Figure 38. HAL Allergy Recent Developments and Future Plans
Figure 39. Intrommune Therapeutics Recent Developments and Future Plans
Figure 40. Global Peanut Allergy Therapeutics Revenue Share by Players in 2021
Figure 41. Peanut Allergy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 42. Global Top 3 Players Peanut Allergy Therapeutics Revenue Market Share in 2021
Figure 43. Global Top 10 Players Peanut Allergy Therapeutics Revenue Market Share in 2021
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 45. Global Peanut Allergy Therapeutics Revenue Share by Type in 2021
Figure 46. Global Peanut Allergy Therapeutics Market Share Forecast by Type (2023-2028)
Figure 47. Global Peanut Allergy Therapeutics Revenue Share by Distribution Channel in 2021
Figure 48. Global Peanut Allergy Therapeutics Market Share Forecast by Distribution Channel (2023-2028)
Figure 49. North America Peanut Allergy Therapeutics Sales Market Share by Type (2017-2028)
Figure 50. North America Peanut Allergy Therapeutics Sales Market Share by Distribution Channel (2017-2028)
Figure 51. North America Peanut Allergy Therapeutics Revenue Market Share by Country (2017-2028)
Figure 52. United States Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Canada Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Mexico Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Europe Peanut Allergy Therapeutics Sales Market Share by Type (2017-2028)
Figure 56. Europe Peanut Allergy Therapeutics Sales Market Share by Distribution Channel (2017-2028)
Figure 57. Europe Peanut Allergy Therapeutics Revenue Market Share by Country (2017-2028)
Figure 58. Germany Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. France Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. United Kingdom Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Russia Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Italy Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Asia-Pacific Peanut Allergy Therapeutics Sales Market Share by Type (2017-2028)
Figure 64. Asia-Pacific Peanut Allergy Therapeutics Sales Market Share by Distribution Channel (2017-2028)
Figure 65. Asia-Pacific Peanut Allergy Therapeutics Revenue Market Share by Region (2017-2028)
Figure 66. China Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Japan Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South Korea Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. India Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Southeast Asia Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Australia Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South America Peanut Allergy Therapeutics Sales Market Share by Type (2017-2028)
Figure 73. South America Peanut Allergy Therapeutics Sales Market Share by Distribution Channel (2017-2028)
Figure 74. South America Peanut Allergy Therapeutics Revenue Market Share by Country (2017-2028)
Figure 75. Brazil Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Argentina Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Middle East and Africa Peanut Allergy Therapeutics Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Peanut Allergy Therapeutics Sales Market Share by Distribution Channel (2017-2028)
Figure 79. Middle East and Africa Peanut Allergy Therapeutics Revenue Market Share by Country (2017-2028)
Figure 80. Turkey Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. UAE Peanut Allergy Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
